GI Innovation Inc
KOSDAQ:358570
Intrinsic Value
GI Innovation, Inc. engages in the development of biopharmaceutical products. [ Read More ]
The intrinsic value of one GI Innovation Inc stock under the Base Case scenario is 15 404.58 KRW. Compared to the current market price of 13 620 KRW, GI Innovation Inc is Undervalued by 12%.
Valuation Backtest
GI Innovation Inc
Run backtest to discover the historical profit from buying and selling GI Innovation Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
GI Innovation Inc
Current Assets | 57B |
Cash & Short-Term Investments | 54.2B |
Receivables | 2.1B |
Other Current Assets | 578.8m |
Non-Current Assets | 34.3B |
Long-Term Investments | 16B |
PP&E | 9.3B |
Intangibles | 1.6B |
Other Non-Current Assets | 7.3B |
Current Liabilities | 4.2B |
Accrued Liabilities | 58.1m |
Other Current Liabilities | 4.1B |
Non-Current Liabilities | 4.3B |
Long-Term Debt | 3B |
Other Non-Current Liabilities | 1.2B |
Earnings Waterfall
GI Innovation Inc
Revenue
|
587.9m
KRW
|
Operating Expenses
|
-67.3B
KRW
|
Operating Income
|
-66.7B
KRW
|
Other Expenses
|
-12.4B
KRW
|
Net Income
|
-79.1B
KRW
|
Free Cash Flow Analysis
GI Innovation Inc
Profitability Score
Profitability Due Diligence
GI Innovation Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
GI Innovation Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
GI Innovation Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
GI Innovation Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
GI Innovation Inc
According to Wall Street analysts, the average 1-year price target for GI Innovation Inc is 23 715 KRW with a low forecast of 21 715 KRW and a high forecast of 26 250 KRW.
Shareholder Return
Price
GI Innovation Inc
Average Annual Return |
N/A
|
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -58% |
Market Capitalization | 600.7B KRW |
Shares Outstanding | 44 131 600 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
GI Innovation, Inc. engages in the development of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 88 full-time employees. The company went IPO on 2023-03-30. The firm is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Contact
IPO
Employees
Officers
The intrinsic value of one GI Innovation Inc stock under the Base Case scenario is 15 404.58 KRW.
Compared to the current market price of 13 620 KRW, GI Innovation Inc is Undervalued by 12%.